Spring Bank Pharmaceuticals, Inc. — Form D

Spring Bank Pharmaceuticals, Inc. of HOPKINTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-03. The offering totals $6.3M, of which $6.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Guy Francis MacdonaldDirectorMilford, MA
Nezam Ellsworth AfdhalExecutive OfficerMilford, MA
Gregg Ellsworth BeloffExecutive OfficerMilford, MA
Michael Francis CroninExecutive OfficerMilford, MA
Donald Moore MitchellExecutive OfficerMilford, MA
Martin DriscollDirectorSouthlake, TX
Martin DriscollExecutive OfficerSouthlake, TX
Jonathan Kris BatesDirectorHopkinton, MA
R.P. Kris IyerDirectorHopkinton, MA
David Kris ArkowitzDirectorHopkinton, MA
Nezam AfdhalExecutive OfficerHopkinton, MA
Jonathan FreveExecutive OfficerHopkinton, MA
David Ellsworth ArkowitzDirectorMilford, MA
Radhakrishnan Parameswaran IyerDirectorMilford, MA
Radhakrishnan Parameswaran IyerExecutive OfficerMilford, MA
Jonathan Ellsworth BatesDirectorMilford, MA
Guy Parameswaran MacdonaldDirectorMilford, MA
Douglas John JensenDirectorMilford, MA
Douglas John JensenExecutive OfficerMilford, MA
Jonathon Ellsworth BatesDirectorMilford, MA
Kurt M EichlerDirectorMarietta, GA

Other filings by this issuer (4)

FiledFormOfferingSold
2016-11-23D$15.0M$15.0M
2015-02-27D/A$21.6M$21.6M
2015-01-14D$15.0M$11.6M
2013-01-25D$8.0M$4.2M

More